Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Oncofertility
  • Reduced price
Substance Use Disorders

Substance Use Disorders

9780190920197
435.24 zł
391.72 zł Save 43.52 zł Tax included
Lowest price within 30 days before promotion: 391.72 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Substance Use Disorders provides an overview of substance misuse and addresses the neurobiology, pharmacotherapy, and behavioural therapy management of substance use disorders from a clinical perspective. Examining the opioid epidemic to frame its discussion of the epidemiology of substance misuse, this book explores common barriers that prevent the implementation of effective treatment. Chapters discuss various aspects of substance use disorders, particularly opioids,alcohol, cannabis, and cocaine, to inform better conceptualization and management of these conditions. Part of the Primer On Psychiatry series, this book will provide a solid foundation for residents and fellows in psychiatry and addiction medicine and can also be used in clinical practice.
Product Details
OUP USA
89262
9780190920197
9780190920197

Data sheet

Publication date
2020
Issue number
1
Cover
paperback
Pages count
384
Dimensions (mm)
178 x 254
Weight (g)
703
  • Chapter 1: Epidemiology of Substance Use Disorders: Opioid Use Disorder Epidemic; Chapter 2: Epidemiology of Cannabis Use Disorder: Neural Substrates & Treatment; Chapter 3: Preclinical Models of Substance Use Disorder: Abuse Liability Assessment and Candidate Pharmacotherapy Evaluation; Chapter 4: Impulsivity and Drug-Seeking Behavior in Substance Misuse: A Preclinical Perspective; Chapter 5: Impulsivity and Cue Reactivity in Substance Misuse: Clinical Studies; Chapter 6: Stress and Substance Misuse; Chapter 7: Overview: Barriers and Advantages of Utilization of FDA Approved Medications for Substance Use Disorder; Chapter 8: Methadone for Opioid Use Disorder; Chapter 9: Use of Buprenorphine for the Treatment of Opioid Use Disorder; Chapter 10: Antagonist Treatment for Opioid Use Disorder: Development of Antagonist Treatment. Antagonists vs. Agonist Treatments Pros and Cons; Chapter 11: Pharmacotherapy for Opioid Use Disorders in Special Populations; Chapter 12: Pharmacology of Alcohol Use Disorder; Chapter 13: Pharmacotherapy for Smoking Cessation: Overview of Medications Including Over-the-Counter Nicotine Replacement Therapy, Bupropion and Varenicline; Chapter 14: What is Evidence Based Treatment?; Chapter 15: Evidence Based Behavioral Therapies for Substance Use Disorder; Chapter 16: Evidence Based Pharmacotherapy for Cocaine, Amphetamine, and Methamphetamine Use Disorder: Overview and History of Clinical Trials; Chapter 17: Evidence Based Pharmacotherapy for Alcohol Use Disorder; Chapter 18: Turn the Next Page: Envisioning the Future of Addiction Therapeutics;
Comments (0)

  • Frequently purchased together

    No products available